Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma-Reference-Cited by-同舟云学术

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Published:2015-10 Issue:8 Volume:38 Page:330-339
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Nguyen-Pham Thanh-Nhan,Jung Sung-Hoon,Vo Manh-Cuong,Thanh-Tran Huong-Thi,Lee Youn-Kyung,Lee Hyun-Ju,Choi Nu-Ri,Hoang My-Dung,Kim Hyeoung-Joon,Lee Je-Jung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference4 articles.

1. Risk adapted therapy for multiple myeloma: back to basics.;Kumar;Leuk Lymphoma,2014

2. Immune dysfuction in multiple myeloma.;Parrish;Int J Hematol Oncol,2013

3. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis.;Shibuya;Genes Cancer,2011

4. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy.;Niu;Curr Drug Targets,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment;Microvascular Research;2024-07

2. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03

3. Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2024-02-12

4. Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications;Current Oncology;2023-06-25

5. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18